FSGS-Causing INF2 Mutation Impairs Cleaved INF2 N-Fragment Functions in Podocytes
-
- Balajikarthick Subramanian
- Division of Nephrology, Department of Medicine, and
-
- Justin Chun
- Division of Nephrology, Department of Medicine, and
-
- Chandra Perez-Gill
- Division of Nephrology, Department of Medicine, and
-
- Paul Yan
- Division of Nephrology, Department of Medicine, and
-
- Isaac E. Stillman
- Department of Pathology, Beth Israel Deaconess Medical center, Harvard Medical School, Boston, Massachusetts;
-
- Henry N. Higgs
- Department of Biochemistry, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire; and
-
- Seth L. Alper
- Division of Nephrology, Department of Medicine, and
-
- Johannes S. Schlöndorff
- Division of Nephrology, Department of Medicine, and
-
- Martin R. Pollak
- Division of Nephrology, Department of Medicine, and
説明
<jats:sec> <jats:title>Background</jats:title> <jats:p>Mutations in the gene encoding inverted formin-2 (INF2), a member of the formin family of actin regulatory proteins, are among the most common causes of autosomal dominant FSGS. INF2 is regulated by interaction between its N-terminal diaphanous inhibitory domain (DID) and its C-terminal diaphanous autoregulatory domain (DAD). INF2 also modulates activity of other formins, such as the mDIA subfamily, and promotes stable microtubule assembly. Why the disease-causing mutations are restricted to the N terminus and how they cause human disease has been unclear.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>We examined INF2 isoforms present in podocytes and evaluated INF2 cleavage as an explanation for immunoblot findings. We evaluated the expression of INF2 N- and C-terminal fragments in human kidney disease conditions. We also investigated the localization and functions of the DID-containing N-terminal fragment in podocytes and assessed whether the FSGS-associated R218Q mutation impairs INF2 cleavage or the function of the N-fragment.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>The INF2-CAAX isoform is the predominant isoform in podocytes. INF2 is proteolytically cleaved, a process mediated by cathepsin proteases, liberating the N-terminal DID to function independently. Although the N-terminal region normally localizes to podocyte foot processes, it does not do so in the presence of FSGS-associated INF2 mutations. The C-terminal fragment localizes to the cell body irrespective of INF2 mutations. In podocytes, the N-fragment localizes to the plasma membrane, binds mDIA1, and promotes cell spreading in a cleavage-dependent way. The disease-associated R218Q mutation impairs these N-fragment functions but not INF2 cleavage.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>INF2 is cleaved into an N-terminal DID–containing fragment and a C-terminal DAD–containing fragment. Cleavage allows the N-terminal fragment to function independently and helps explain the clustering of FSGS-associated mutations.</jats:p> </jats:sec>
収録刊行物
-
- Journal of the American Society of Nephrology
-
Journal of the American Society of Nephrology 31 (2), 374-391, 2020-01-10
Ovid Technologies (Wolters Kluwer Health)